Quantitative Xylazine Measurement in ED
NCT06949605 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75
Last updated 2026-03-25
Summary
Quantitative Xylazine Measurement Among Non-Fatal Opioid Overdose (OD) Patients in the Emergency Department (ED)
Conditions
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
Icahn School of Medicine at Mount Sinai
lead OTHER
Principal Investigators
-
Jennifer Love, MD, MS · Icahn School of Medicine
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-04-01
- Primary Completion
- 2026-02-28
- Completion
- 2026-02-28
Countries
- United States
Study Locations
More Related Trials
-
The Incidence, Clinical Characteristics and Outcome of Infective Endocarditis Among Intravenous Drug Abusers Versus Non-Drug Abusers.
NCT06194409 ·Status: RECRUITING
-
The Effects of ∆-9-THC and Naloxone in Humans
NCT01591629 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effects of Cannabis on Prescription Drug Abuse Liability and Analgesia
NCT03679949 ·Status: COMPLETED ·Phase: PHASE1
-
The NeXT Study; The Netherlands XTC Toxicity Study
NCT00235768 ·Status: COMPLETED
-
Circulating Oxytocin Changes in Response to the Oxytocin System Stimulator MDMA in Patients With Diabetes Insipidus and Healthy Controls
NCT04648137 ·Status: COMPLETED ·Phase: NA
-
Functional Brain Imaging in Recreational Users of Ecstasy
NCT00254306 ·Status: COMPLETED
-
Neurobiology of Opioid Dependence: 1 - 1
NCT00000192 ·Status: WITHDRAWN ·Phase: PHASE2
-
Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)
NCT06160284 ·Status: RECRUITING ·Phase: PHASE1
-
Mapping Ibogaine Neural Dynamics in Opioid Use Disorder
NCT07226570 ·Status: RECRUITING
-
Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7
NCT00000255 ·Status: COMPLETED ·Phase: PHASE2
-
Generate and Test the Reliability of a PD Model of OXT on Pupillary Hippus as a Measure of CNS Activity
NCT04427709 ·Status: RECRUITING ·Phase: PHASE2
-
Pharmacokinetics, Safety, and Tolerability of Intramuscular 5-MeO-DMT in Healthy Volunteers
NCT05698095 ·Status: COMPLETED ·Phase: PHASE1
-
Opiates and Benzodiazepines on Driving
NCT03447353 ·Status: COMPLETED ·Phase: PHASE4
-
Comparing Haloperidol to Olanzapine in the Treatment of Suspected Cannabinoid Hyperemesis in the Emergency Department
NCT07246187 ·Status: RECRUITING ·Phase: PHASE3
-
Low Dose Ketamine Intra Nasal Traumatology
NCT03233035 ·Status: COMPLETED ·Phase: PHASE2
-
Influence of Medication on Functional Connectivity
NCT03612713 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Influence of Δ9-tetrahydrocannabinol (THC) on Oxycodone Induced Ventilatory Depression in Healthy Volunteers
NCT05235503 ·Status: UNKNOWN ·Phase: PHASE4
-
Endogenous Opioid Modulation by Ketamine
NCT03051945 ·Status: WITHDRAWN ·Phase: PHASE3
-
Study of the Effects of MDMA/Ecstasy on Water Regulation, Sleep, and Cognition.
NCT01053403 ·Status: COMPLETED ·Phase: NA
-
Effect of Oxytocin on Craving and Therapy Response
NCT01827332 ·Status: COMPLETED ·Phase: NA
-
Quantification of Drugs and Their Degradation Products
NCT01828372 ·Status: UNKNOWN ·Phase: NA
-
Single Ascending Dose Study With 5-MeO-DMT in Healthy Subjects
NCT05032833 ·Status: COMPLETED ·Phase: PHASE1
-
Prevalence of New Psychoactive Substances Use
NCT03695419 ·Status: UNKNOWN
-
Effects of Nitrous Oxide: A Dose-Response Analysis - 5
NCT00000253 ·Status: COMPLETED ·Phase: NA
-
Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4
NCT00000252 ·Status: COMPLETED ·Phase: PHASE2